Fisetin Nanotherapeutics for Cancer Prevention and Treatment: Bioavailability, Preclinical Efficacy, and Translational Challenges

Fisetin, a polyphenolic compound derived from Venetian sumach (Rhus cotinus L.), exhibits notable antioxidant, neuroprotective, anti-inflammatory, and senolytic effects. The compound Fisetin is a secondary metabolite. Chemically, it is known as 2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-4H-1-benzopyran-4-one, 3,3′,4′,7-tetrahydroxyflavone, or 5-deoxy quercetin. Presently, it is obtained from various plants. This bioactive molecule is also reported to exhibit anticancer potential, and researchers have shown promising activity in the management of various cancers, including oral, breast, lung, and brain cancers, as well as other malignancies. Despite holding significant promise, as with other natural compounds, this molecule is associated with challenges such as poor aqueous solubility, compromised bioavailability, greater lipophilicity, and uneven pharmacokinetic distribution. This review highlights the research-based evidence for Fisetin in cancer treatment and emphasizes nanotechnology-based approaches employing this bioactive molecule across various cancers. Examining fisetin’s clinical trials helps chart its evolution from a dietary supplement to a promising anticancer drug.

Authors

Institutions

Publication Details

Journal
Pharmaceutics
Published
2026-11-18
DOI
https://doi.org/10.3390/pharmaceutics18111491
Primary Topic
Flavonoids in Medical Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Fisetin Nanotherapeutics for Cancer Prevention and Treatment: Bioavailability, Preclinical Efficacy, and Translational Challenges

Harshita Abul Barkat, Abdulkareem Ali Alanezi, Hajed Obaid Alharbi, Afaf F. Almuqati et al.
2 links
Pharmaceutics
Flavonoids in Medical Research
article

Fisetin Nanotherapeutics for Cancer Prevention and Treatment: Bioavailability, Preclinical Efficacy, and Translational Challenges

Harshita Abul Barkat, Abdulkareem Ali Alanezi, Hajed Obaid Alharbi, Afaf F. Almuqati, Fahad Saad Alhodieb, Mohammad Azam Ansari, Md. Abul Barkat, Arshad Husain Rahmani, Tarique Sarwar, Abrar Turki
article en

Abstract

Fisetin, a polyphenolic compound derived from Venetian sumach (Rhus cotinus L.), exhibits notable antioxidant, neuroprotective, anti-inflammatory, and senolytic effects. The compound Fisetin is a secondary metabolite. Chemically, it is known as 2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-4H-1-benzopyran-4-one, 3,3′,4′,7-tetrahydroxyflavone, or 5-deoxy quercetin. Presently, it is obtained from various plants. This bioactive molecule is also reported to exhibit anticancer potential, and researchers have shown promising activity in the management of various cancers, including oral, breast, lung, and brain cancers, as well as other malignancies. Despite holding significant promise, as with other natural compounds, this molecule is associated with challenges such as poor aqueous solubility, compromised bioavailability, greater lipophilicity, and uneven pharmacokinetic distribution. This review highlights the research-based evidence for Fisetin in cancer treatment and emphasizes nanotechnology-based approaches employing this bioactive molecule across various cancers. Examining fisetin’s clinical trials helps chart its evolution from a dietary supplement to a promising anticancer drug.

PharmaceuticsVol. 18(11)
Qassim University (SA), University of Hafr Al-Batin (SA), Imam Abdulrahman Bin Faisal University (SA)
Good health and well-being
Flavonoids in Medical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon